San Francisco, California, USA
19th – 20th October 2016
Delegates attending this course benefit from an introductory overview of the terminology and classification of cancer and the principle issues in its treatment. Commonly available anti-cancer drugs including immunotherapies are reviewed with emphasis on mode of action, dose intensity and chemotherapy regimes. The range of side effects of cancer treatments is studied in detail. Quality of life issues in terms of overall assessment and result interpretation are discussed too.
Detailed consideration is given to the treatment of major tumor types: breast, lung, upper gastrointestinal (GI), colorectal, ovarian and prostate cancer and melanoma. Each session is presented by clinicians active in these areas and will focus on overall patient presentation and management and cancer diagnosis and staging. Following these sessions, our experts will lead delegates in interactive group discussions on the key issues relating to effective management of each tumor type.
The limitations of cytotoxic drugs currently available are well known. With this in mind, the course includes in-depth discussion on new drug development and identification of new pharmacological targets of particular interest and value. Clinical trial design issues will also be included.
Who should attend? Healthcare’s courses are designed for both medical and non-medical staff within the pharmaceutical industry. This course is suitable for clinical research, medical information, regulatory affairs, biometrics and strategic marketing personnel.
Topics to be covered include:
- Cancer: terminology and classification
- Introduction to anti-cancer drugs and side effects
- New developments in cancer therapy
- Introduction to the major tumor types: breast, lung, colorectal, ovarian, upper GI and prostate cancer and melanoma
- Clinical trial issues in oncology
John Chan, MD, USCF Helen Diller Family Comprehensive Cancer Center, SF, USA
Jeffrey Crawford, MD, Duke University Medical Center, North Carolina
Charles J Ryan, MD, USCF Helen Diller Family Comprehensive Cancer Center, SF, USA
Alan Venook, MD, USCF Helen Diller Family Comprehensive Cancer Center, SF, USA